These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1209 related items for PubMed ID: 27094481

  • 1. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA, Collins IM, Milne RL, McLachlan SA, Friedlander M, Hickey M, Stern C, Hopper JL, Fisher R, Kannemeyer G, Picken S, Smith CD, Kelsey TW, Anderson RA, Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab).
    Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
    [Abstract] [Full Text] [Related]

  • 2. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
    van Tilborg TC, Derks-Smeets IA, Bos AM, Oosterwijk JC, van Golde RJ, de Die-Smulders CE, van der Kolk LE, van Zelst-Stams WA, Velthuizen ME, Hoek A, Eijkemans MJ, Laven JS, Ausems MG, Broekmans FJ.
    Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901
    [Abstract] [Full Text] [Related]

  • 3. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study.
    Winship AL, Willson C, Hansen KR, Hutt KJ, Hickey M.
    BMJ Open; 2019 Nov 25; 9(11):e033810. PubMed ID: 31772111
    [Abstract] [Full Text] [Related]

  • 4. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
    Winship AL, Griffiths M, Lliberos Requesens C, Sarma U, Phillips KA, Hutt KJ.
    Hum Reprod; 2020 Aug 01; 35(8):1864-1874. PubMed ID: 32604417
    [Abstract] [Full Text] [Related]

  • 5. Assessment of ovarian reserve and reproductive outcomes in BRCA1 or BRCA2 mutation carriers.
    Ponce J, Fernandez-Gonzalez S, Calvo I, Climent M, Peñafiel J, Feliubadaló L, Teulé A, Lázaro C, Brunet JM, Candás-Estébanez B, Durán Retamal M.
    Int J Gynecol Cancer; 2020 Jan 01; 30(1):83-88. PubMed ID: 31780568
    [Abstract] [Full Text] [Related]

  • 6. BRCA1 germline mutations may be associated with reduced ovarian reserve.
    Wang ET, Pisarska MD, Bresee C, Chen YD, Lester J, Afshar Y, Alexander C, Karlan BY.
    Fertil Steril; 2014 Dec 01; 102(6):1723-8. PubMed ID: 25256924
    [Abstract] [Full Text] [Related]

  • 7. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K, Hvidman HW, Forman JL, Pinborg A, Larsen EC, Macklon KT, Sylvest R, Andersen AN.
    Hum Reprod; 2015 Oct 01; 30(10):2364-75. PubMed ID: 26311148
    [Abstract] [Full Text] [Related]

  • 8. Conditional loss of Brca1 in oocytes causes reduced litter size, ovarian reserve depletion and impaired oocyte in vitro maturation with advanced reproductive age in mice.
    Winship AL, Alesi LR, Stringer JM, Cao Y, Lewis YM, Tu L, Swindells EOK, Giridharan S, Cai X, Griffiths MJ, Zerafa N, Gilham L, Hickey M, Hutt KJ.
    EBioMedicine; 2024 Aug 01; 106():105262. PubMed ID: 39084071
    [Abstract] [Full Text] [Related]

  • 9. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG, van der Schouw YT, van Gils CH, Verschuren WMM, Broekmans FJM, Borges MC, Gonçalves Soares AL, Lawlor DA, Eliassen AH, Kraft P, Sandler DP, Harlow SD, Smith JA, Santoro N, Schoemaker MJ, Swerdlow AJ, Murray A, Ruth KS, Onland-Moret NC.
    Hum Reprod; 2022 May 03; 37(5):1069-1082. PubMed ID: 35274129
    [Abstract] [Full Text] [Related]

  • 10. Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.
    Denis-Laroque L, Drouet Y, Plotton I, Chopin N, Bonadona V, Lornage J, Salle B, Lasset C, Rousset-Jablonski C.
    Breast; 2021 Oct 03; 59():239-247. PubMed ID: 34304065
    [Abstract] [Full Text] [Related]

  • 11. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M, Dagher Hayeck B, Papanikolaou EG, Sifer C, Sermondade N, Sonigo C.
    Hum Reprod; 2019 Feb 01; 34(2):374-379. PubMed ID: 30561604
    [Abstract] [Full Text] [Related]

  • 12. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ, Islam RM, Skiba MA, Herbert D, Martinez Garcia A, Davis SR.
    Hum Reprod; 2021 Dec 27; 37(1):109-118. PubMed ID: 34741176
    [Abstract] [Full Text] [Related]

  • 13. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW, Bentzen JG, Thuesen LL, Lauritsen MP, Forman JL, Loft A, Pinborg A, Nyboe Andersen A.
    Hum Reprod; 2016 May 27; 31(5):1034-45. PubMed ID: 26965431
    [Abstract] [Full Text] [Related]

  • 14. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P, van de Vijver A, Schutyser V, Milatovic S, Anckaert E, Schiettecatte J, Blockeel C, Camus M, Tournaye H, Polyzos NP.
    Hum Reprod; 2017 Jan 27; 32(1):208-214. PubMed ID: 27927849
    [Abstract] [Full Text] [Related]

  • 15. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.
    Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G, Kathleen Cuningham Consortium for Research in Familial Breast Cancer.
    Breast Cancer Res; 2006 Jan 27; 8(1):R12. PubMed ID: 16507150
    [Abstract] [Full Text] [Related]

  • 16. The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study.
    de Kat AC, Verschuren WM, Eijkemans MJ, van der Schouw YT, Broekmans FJ.
    Hum Reprod; 2016 Aug 27; 31(8):1866-74. PubMed ID: 27496945
    [Abstract] [Full Text] [Related]

  • 17. Antimüllerian hormone levels are lower in BRCA2 mutation carriers.
    Johnson L, Sammel MD, Domchek S, Schanne A, Prewitt M, Gracia C.
    Fertil Steril; 2017 May 27; 107(5):1256-1265.e6. PubMed ID: 28476184
    [Abstract] [Full Text] [Related]

  • 18. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K, Grigorova M, Ehrenberg A, Vaas P, Sekavin A, Nõmmemees D, Adler M, Hanson E, Juhanson P, Laan M.
    Hum Reprod; 2018 May 01; 33(5):954-966. PubMed ID: 29617818
    [Abstract] [Full Text] [Related]

  • 19. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay.
    Han X, McShane M, Sahertian R, White C, Ledger W.
    Hum Reprod; 2014 May 01; 29(5):1042-8. PubMed ID: 24626805
    [Abstract] [Full Text] [Related]

  • 20. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
    Oktay KH, Bedoschi G, Goldfarb SB, Taylan E, Titus S, Palomaki GE, Cigler T, Robson M, Dickler MN.
    Fertil Steril; 2020 Jun 01; 113(6):1251-1260.e1. PubMed ID: 32331767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.